$1.19
-0.11-8.46%
At close: -
$1.20
0.010.84%
After Hours: 7:36 PM EDT
Comments
Loading...
Allakos (NASDAQ:ALLK) Stock Quotes, Forecast and News Summary
Allakos Stock (NASDAQ: ALLK) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Allakos (ALLK) stock?
You can purchase shares of Allakos (NASDAQ:ALLK) through any online brokerage.
Who are Allakos (ALLK) competitors?
Other companies in Allakos’s space includes: Cabaletta Bio (NASDAQ:CABA), PepGen (NASDAQ:PEPG), Atossa Therapeutics (NASDAQ:ATOS), OS Therapies (AMEX:OSTX) and Lineage Cell Therapeutics (AMEX:LCTX).
What is the forecast, or price target, for Allakos (ALLK) stock?
Allakos has a consensus price target of $7.50.
What is the current price for Allakos (ALLK)?
The stock price for Allakos (NASDAQ: ALLK) is $1.2 last updated December 30, 2024 at 7:36 PM EST.
Does Allakos (ALLK) pay a dividend?
There are no upcoming dividends for Allakos.
When is Allakos (NASDAQ:ALLK) reporting earnings?
Allakos’s Q4 earnings are confirmed for Thursday, March 13, 2025.
Is Allakos (ALLK) going to split?
There is no upcoming split for Allakos.
What sector and industry does Allakos (ALLK) operate in?
Allakos is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.